Skip to the page

Data / Crowdfunding / California / KronosMD, Inc.

KronosMD, Inc.: crowdfunding raise on PicMii Crowdfunding LLC, $10,000 to $5,000,000 (2026)

KronosMD, Inc., a corporation in Thousand Oaks, CA, filed a Form C with the SEC on October 27, 2026 to raise $10,000 to $5,000,000 in preferred stock through PicMii Crowdfunding LLC. The offering closes on April 18, 2027. In its most recent fiscal year it reported $0 in revenue and a net loss of $10,179, with 1 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
kronosmd.com
Funding portal
PicMii Crowdfunding LLC
Address
1000 NEWBURY RD., SUITE 290 B, Thousand Oaks, CA 91320
Legal form
Corporation
Jurisdiction
CO
Incorporated
October 7, 2022
SEC CIK
0002131547

Offering terms

From the offering filed October 27, 2026.

Security
Preferred Stock
Price
$1.00
Target
$10,000
Maximum
$5,000,000
Deadline
April 18, 2027
Portal compensation
Intermediary will receive 4.9% of the final raised funds and a $3,500 listing fee.

Financials

From the Form C filed October 27, 2026.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$0sec.gov
Cost of goods sold$0$0sec.gov
Net income$-10,179$-179sec.gov
Taxes paid$0$0sec.gov
Total assets$5,167,580$5,167,580sec.gov
Cash$582$761sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$10,000$0sec.gov
Long-term debt$0$0sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
October 27, 2026Offering$10,000$5,000,000April 18, 2027sec.gov

All filings on sec.gov

Updated October 27, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.